Region-specific Effects of Oestradiol on Adipose-derived Stem Cell Differentiation in Post-menopausal Women

Overview

Journal J Cell Mol Med

Specialties Cell Biology
Molecular Biology

Date 2016 Nov 19

PMID 27862950

Citations 14

Authors

Kimberly A Cox-York

Christopher B Erickson

Rocio I Pereira

Daniel H Bessesen

Rachael E Van Pelt

Affiliations

Soon will be listed here.

Abstract

The goal of this study was to determine the effect of acute transdermal 17β-oestradiol (E ) on the adipogenic potential of subcutaneous adipose-derived stem cells (ASC) in post-menopausal women. Post-menopausal women (n = 11; mean age 57 ± 4.5 years) were treated for 2 weeks, in a randomized, cross-over design, with transdermal E (0.15 mg) or placebo patches. Biopsies of abdominal (AB) and femoral (FEM) subcutaneous adipose tissue (SAT) were obtained after each treatment and mature adipocytes were analysed for cell size and ASC for their capacity for proliferation (growth rate), differentiation (triglyceride accumulation) and susceptibility to tumour necrosis factor alpha-induced apoptosis. Gene expression of oestrogen receptors α and β (ESR1 and ESR2), perilipin 1 and hormone-sensitive lipase (HSL), was also assessed. In FEM SAT, but not AB SAT, 2 weeks of E significantly (P = 0.03) increased ASC differentiation and whole SAT HSL mRNA expression (P = 0.03) compared to placebo. These changes were not associated with mRNA expression of oestrogen receptors α and β, but HSL expression was significantly increased in FEM SAT with transdermal E treatment. Adipose-derived stem cells proliferation and apoptosis did not change in either SAT depot after E compared with placebo. Short-term E appeared to increase the adipogenic potential of FEM, but not AB, SAT in post-menopausal women with possible implications for metabolic disease. Future studies are needed to determine longer term impact of E on regional SAT accumulation in the context of positive energy imbalance.

Citing Articles

Tanfloc-Modified Titanium Surfaces: Optimizing Blood Coagulant Activity and Stem Cell Compatibility.

Singh R, Madruga L, Savargaonkar A, Martins A, Kipper M, Popat K ACS Biomater Sci Eng. 2025; 11(3):1445-1455.

PMID: 40013664 PMC: 11897940. DOI: 10.1021/acsbiomaterials.4c02106.

Human adipose depots' diverse functions and dysregulations during cardiometabolic disease.

Ziegler A, Scheele C NPJ Metab Health Dis. 2024; 2(1):34.

PMID: 39619657 PMC: 11606922. DOI: 10.1038/s44324-024-00036-z.

Accounting for genetic effect heterogeneity in fine-mapping and improving power to detect gene-environment interactions with SharePro.

Zhang W, Sladek R, Li Y, Najafabadi H, Dupuis J Nat Commun. 2024; 15(1):9374.

PMID: 39478020 PMC: 11526169. DOI: 10.1038/s41467-024-53818-w.

The Expression of Adipogenic Marker Is Significantly Increased in Estrogen-Treated Lipedema Adipocytes Differentiated from Adipose Stem Cells In Vitro.

Al-Ghadban S, Isern S, Herbst K, Bunnell B Biomedicines. 2024; 12(5).

PMID: 38791004 PMC: 11117526. DOI: 10.3390/biomedicines12051042.

Expanding the Scope of an Amphoteric Condensed Tannin, Tanfloc, for Antibacterial Coatings.

Baghersad S, Madruga L, Martins A, Popat K, Kipper M J Funct Biomater. 2023; 14(11).

PMID: 37998123 PMC: 10672460. DOI: 10.3390/jfb14110554.

References

Lundholm L, Zang H, Linden Hirschberg A, Gustafsson J, Arner P, Dahlman-Wright K . Key lipogenic gene expression can be decreased by estrogen in human adipose tissue. Fertil Steril. 2008; 90(1):44-8. DOI: 10.1016/j.fertnstert.2007.06.011. View

Virtue S, Vidal-Puig A . Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome--an allostatic perspective. Biochim Biophys Acta. 2010; 1801(3):338-49. DOI: 10.1016/j.bbalip.2009.12.006. View

Dieudonne M, Pecquery R, Leneveu M, Giudicelli Y . Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor gamma2. Endocrinology. 2000; 141(2):649-56. DOI: 10.1210/endo.141.2.7293. View

Monroe D, McIntosh M . Dehydroepiandrosterone and related steroids alter 3T3-L1 preadipocyte proliferation and differentiation. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1999; 123(1):17-25. DOI: 10.1016/s0742-8413(99)00003-1. View

Arner E, Westermark P, Spalding K, Britton T, Ryden M, Frisen J . Adipocyte turnover: relevance to human adipose tissue morphology. Diabetes. 2009; 59(1):105-9. PMC: 2797910. DOI: 10.2337/db09-0942. View

Gambacciani M, Ciaponi M, Cappagli B, Piaggesi L, De Simone L, Orlandi R . Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. J Clin Endocrinol Metab. 1997; 82(2):414-7. DOI: 10.1210/jcem.82.2.3735. View

Tchoukalova Y, Koutsari C, Votruba S, Tchkonia T, Giorgadze N, Thomou T . Sex- and depot-dependent differences in adipogenesis in normal-weight humans. Obesity (Silver Spring). 2010; 18(10):1875-80. PMC: 2906626. DOI: 10.1038/oby.2010.56. View

Clegg D, Brown L, Woods S, Benoit S . Gonadal hormones determine sensitivity to central leptin and insulin. Diabetes. 2006; 55(4):978-87. DOI: 10.2337/diabetes.55.04.06.db05-1339. View

Mitterberger M, Lechner S, Mattesich M, Zwerschke W . Adipogenic differentiation is impaired in replicative senescent human subcutaneous adipose-derived stromal/progenitor cells. J Gerontol A Biol Sci Med Sci. 2013; 69(1):13-24. DOI: 10.1093/gerona/glt043. View

10.

Jackman M, Steig A, Higgins J, Johnson G, Fleming-Elder B, Bessesen D . Weight regain after sustained weight reduction is accompanied by suppressed oxidation of dietary fat and adipocyte hyperplasia. Am J Physiol Regul Integr Comp Physiol. 2008; 294(4):R1117-29. DOI: 10.1152/ajpregu.00808.2007. View

11.

White U, Tchoukalova Y . Sex dimorphism and depot differences in adipose tissue function. Biochim Biophys Acta. 2013; 1842(3):377-92. PMC: 3926193. DOI: 10.1016/j.bbadis.2013.05.006. View

12.

Faubion S, Kuhle C, Shuster L, Rocca W . Long-term health consequences of premature or early menopause and considerations for management. Climacteric. 2015; 18(4):483-91. PMC: 4581591. DOI: 10.3109/13697137.2015.1020484. View

13.

Davis K, Neinast M, Sun K, Skiles W, Bills J, Zehr J . The sexually dimorphic role of adipose and adipocyte estrogen receptors in modulating adipose tissue expansion, inflammation, and fibrosis. Mol Metab. 2013; 2(3):227-42. PMC: 3773827. DOI: 10.1016/j.molmet.2013.05.006. View

14.

Okazaki R, Inoue D, Shibata M, Saika M, Kido S, Ooka H . Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta. Endocrinology. 2002; 143(6):2349-56. DOI: 10.1210/endo.143.6.8854. View

15.

Heim M, Frank O, Kampmann G, Sochocky N, Pennimpede T, Fuchs P . The phytoestrogen genistein enhances osteogenesis and represses adipogenic differentiation of human primary bone marrow stromal cells. Endocrinology. 2003; 145(2):848-59. DOI: 10.1210/en.2003-1014. View

16.

Baglioni S, Cantini G, Poli G, Francalanci M, Squecco R, Di Franco A . Functional differences in visceral and subcutaneous fat pads originate from differences in the adipose stem cell. PLoS One. 2012; 7(5):e36569. PMC: 3344924. DOI: 10.1371/journal.pone.0036569. View

17.

Yi K, Shin J, Seo H, Lee J, Oh M, Kim T . Role of estrogen receptor-alpha and -beta in regulating leptin expression in 3T3-L1 adipocytes. Obesity (Silver Spring). 2008; 16(11):2393-9. DOI: 10.1038/oby.2008.389. View

18.

Barros R, Gustafsson J . Estrogen receptors and the metabolic network. Cell Metab. 2011; 14(3):289-99. DOI: 10.1016/j.cmet.2011.08.005. View

19.

Di Girolamo M, Mendlinger S, FERTIG J . A simple method to determine fat cell size and number in four mammalian species. Am J Physiol. 1971; 221(3):850-8. DOI: 10.1152/ajplegacy.1971.221.3.850. View

20.

Wend K, Wend P, Krum S . Tissue-Specific Effects of Loss of Estrogen during Menopause and Aging. Front Endocrinol (Lausanne). 2012; 3:19. PMC: 3356020. DOI: 10.3389/fendo.2012.00019. View